The decline in ACE2 levels is deleterious for the control of pulmonary fibrosis because ACE2 is key in metabolizing Ang II, a peptide hormone which is recognized for instigating lung fibrosis by stimulating TGF-β, and without sufficient ACE2, this harmful process is exacerbated. Here, AGT is linked to pulmonary fibrosis.